Insufficient scRNA-seq data for expression of EIF5AL1 at single-cell level.
Insufficient scRNA-seq data for expression of EIF5AL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 92% | 129.07 | 1328 / 1445 | 100% | 4.38 | 183 / 183 |
ovary | 76% | 54.52 | 137 / 180 | 100% | 3.75 | 428 / 430 |
stomach | 84% | 72.27 | 301 / 359 | 85% | 4.16 | 242 / 286 |
skin | 99% | 178.74 | 1789 / 1809 | 69% | 4.05 | 326 / 472 |
intestine | 87% | 88.43 | 841 / 966 | 78% | 3.85 | 411 / 527 |
lung | 92% | 113.07 | 530 / 578 | 67% | 3.34 | 778 / 1155 |
bladder | 86% | 76.52 | 18 / 21 | 66% | 3.28 | 335 / 504 |
uterus | 81% | 69.34 | 138 / 170 | 68% | 3.86 | 310 / 459 |
prostate | 91% | 97.93 | 223 / 245 | 56% | 2.96 | 283 / 502 |
adrenal gland | 96% | 137.49 | 247 / 258 | 49% | 1.84 | 112 / 230 |
thymus | 89% | 90.77 | 578 / 653 | 55% | 2.40 | 332 / 605 |
breast | 92% | 103.04 | 420 / 459 | 49% | 2.20 | 547 / 1118 |
brain | 76% | 58.24 | 2005 / 2642 | 65% | 2.93 | 455 / 705 |
kidney | 84% | 81.85 | 75 / 89 | 51% | 1.90 | 461 / 901 |
pancreas | 78% | 66.38 | 257 / 328 | 54% | 2.57 | 96 / 178 |
liver | 94% | 133.17 | 212 / 226 | 35% | 1.41 | 143 / 406 |
muscle | 96% | 130.63 | 767 / 803 | 0% | 0 | 0 / 0 |
adipose | 92% | 113.47 | 1111 / 1204 | 0% | 0 | 0 / 0 |
spleen | 89% | 102.17 | 214 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 87% | 84.07 | 1163 / 1335 | 0% | 0 | 0 / 0 |
heart | 82% | 78.38 | 703 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 3.92 | 36 / 45 |
peripheral blood | 77% | 97.91 | 719 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 5.50 | 22 / 29 |
eye | 0% | 0 | 0 / 0 | 66% | 5.12 | 53 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045905 | Biological process | positive regulation of translational termination |
GO_0006414 | Biological process | translational elongation |
GO_0045901 | Biological process | positive regulation of translational elongation |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005634 | Cellular component | nucleus |
GO_0043022 | Molecular function | ribosome binding |
GO_0003746 | Molecular function | translation elongation factor activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | EIF5AL1 |
Protein name | Eukaryotic translation initiation factor 5A-1-like (eIF-5A-1-like) (eIF-5A1-like) (Eukaryotic initiation factor 5A isoform 1-like) |
Synonyms | |
Description | FUNCTION: Translation factor that promotes translation elongation and termination, particularly upon ribosome stalling at specific amino acid sequence contexts (By similarity). Binds between the exit (E) and peptidyl (P) site of the ribosome and promotes rescue of stalled ribosome: specifically required for efficient translation of polyproline-containing peptides as well as other motifs that stall the ribosome. Acts as a ribosome quality control (RQC) cofactor by joining the RQC complex to facilitate peptidyl transfer during CAT tailing step (By similarity). Also involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity (By similarity). . |
Accessions | Q6IS14 ENST00000520547.4 |